2nd Quarter - Report
ARNOLD & PORTER KAYE SCHOLER LLP for GENETIX BIOTHERAPEUTICS, INC.
Income
$60,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues and legislation related to access to gene therapies and treatment of rare diseases.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LUKE ALBERT | — |
| RON KIND | — |
| BOBBY MCMILLIN | — |
| SONJA NESBIT | — |
| EUGENIA PIERSON | — |
Health Issues HCR
Issues and legislation related to access to gene therapies and treatment of rare diseases.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LUKE ALBERT | — |
| RON KIND | — |
| BOBBY MCMILLIN | — |
| SONJA NESBIT | — |
| EUGENIA PIERSON | — |
Pharmacy PHA
Issues related to regulatory incentives for rare disease therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BOBBY MCMILLIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.